Processing

Please wait...

Settings

Settings

Goto Application

1. WO2002018412 - 17 HUMAN SECRETED PROTEINS

Publication Number WO/2002/018412
Publication Date 07.03.2002
International Application No. PCT/US2001/001384
International Filing Date 17.01.2001
Chapter 2 Demand Filed 14.03.2002
IPC
A61K 38/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/47 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
C07K 14/705 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
705Receptors; Cell surface antigens; Cell surface determinants
CPC
A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/47
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
C07K 14/4713
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
46from vertebrates
47from mammals
4701not used
4713Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
C07K 14/70571
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
705Receptors; Cell surface antigens; Cell surface determinants
70571for neuromediators, e.g. serotonin receptor, dopamine receptor
Applicants
  • HUMAN GENOME SCIENCES, INC. [US]/[US] (AllExceptUS)
  • ROSEN, Craig, A. [US]/[US] (UsOnly)
  • KOMATSOULIS, George, A. [US]/[US] (UsOnly)
  • BAKER, Kevin, P. [GB]/[US] (UsOnly)
  • BIRSE, Charles, E. [GB]/[US] (UsOnly)
  • SOPPET, Daniel, R. [US]/[US] (UsOnly)
  • OLSEN, Henrik, S. [DK]/[US] (UsOnly)
  • MOORE, Paul, A. [GB]/[US] (UsOnly)
  • WEI, Ping [CN]/[US] (UsOnly)
  • EBNER, Reinhard [DE]/[US] (UsOnly)
  • DUAN, Roxanne, D. [US]/[US] (UsOnly)
  • SHI, Yanggu [CN]/[US] (UsOnly)
  • CHOI, Gil, H. [KR]/[US] (UsOnly)
  • FISCELLA, Michele [IT]/[US] (UsOnly)
  • NI, Jian [CN]/[US] (UsOnly)
Inventors
  • ROSEN, Craig, A.
  • KOMATSOULIS, George, A.
  • BAKER, Kevin, P.
  • BIRSE, Charles, E.
  • SOPPET, Daniel, R.
  • OLSEN, Henrik, S.
  • MOORE, Paul, A.
  • WEI, Ping
  • EBNER, Reinhard
  • DUAN, Roxanne, D.
  • SHI, Yanggu
  • CHOI, Gil, H.
  • FISCELLA, Michele
  • NI, Jian
Agents
  • HOOVER, Kenley, K.
Priority Data
60/228,08628.08.2000US
60/259,51604.01.2001US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) 17 HUMAN SECRETED PROTEINS
(FR) 17 PROTÉINES HUMAINES SÉCRÉTÉES
Abstract
(EN)
The present invention relates to novel human secreted proteins and isolated nucleic acids containing the coding regions of the genes encoding such proteins. Also provided are vectors, host cells, antibodies, and recombinant methods for producing human secreted proteins. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins.
(FR)
La présente invention concerne des protéines humaines sécrétées nouvellement découvertes ainsi que des acides nucléiques isolés contenant les régions de codage des gènes codant de telles protéines. L'invention concerne également des vecteurs, des cellules hôtes, des anticorps et des procédés de recombinaison permettant de produire ces protéines humaines sécrétées. L'invention concerne enfin des procédés de diagnostic et des traitements convenant particulièrement au diagnostic et au traitement de maladies, de troubles, et/ou d'états se rapportant à ces protéines humaines sécrétées nouvellement découvertes.
Also published as
Latest bibliographic data on file with the International Bureau